Following CRL, Form 483 reveals more quality issues at Alvotech’s production facility in Iceland
Another Form 483 for the Icelandic biosimilar manufacturer Alvotech’s manufacturing facility has shed more light on a recent complete response letter from the FDA …
Sign up to read this article for free.
Get free access to a limited number of articles, plus choose newsletters to get straight to your inbox.